Abstract:OBJECTIVE:To explore the features of microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma (HCC) and whether they are in concordance with those in the carcinoma tissues.METHODS:Peripheral blood samples were collected from 62 HCC patients and the corresponding tumor tissues were obtained during operation. Three high-polymorphic microsatellite markers located at chromosome 8p, D8S277, D8S298, and D8S1771, were selected to be used to detect the loss heterozygosity (LOH) and microsatellite instability (MSI) by PCR and sequencing.RESULTS:Joint detection showed that 39 out of the 62 tissue samples showed LOH at all the 3 loci, and the same alterations at the same loci were seen in 33 matched plasma samples with a concordance rate of 84.6%. Nineteen tissue samples showed MSI at all 3 loci, and the same alterations were shown in 14 matched plasma samples with a concordance rate of 73.3%. The rate of LOH for at least one locus in the plasma DNA was 58.1% (36/62), significantly higher than the rate of MSI at at least one locus in the plasma samples (29.0%, 18/62, P < 0.01). The MSI positive rate in the loci D8S277 of the plasma DNA was 22.6%, significantly higher than those of the other 2 loci (4.8% and 4.8% respectively, both P < 0.05). The MSI positive rate at the loci D8S277 of the cancer tissue was 46.8%, significantly higher than those of the other 2 loci (38.7% for D8S298 and 37.1% for D8S1771, both P < 0.05).CONCLUSION:Microsatellite alterations show a high concordant pattern between the tissue and plasma DNA in HCC, which indicates that the microsatellite alterations of tumor tissue are reflected by plasma DNA, LOH may play an important role in hepatocarcinogenesis whereas MSI may also contribute to this progress in a less significant way, and D8S277 is a sensitive locus to MSI in HCC.

Study on Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma

Microsatellite Alterations on Chromosome 8 of Hepatocellular Carcinoma

Involvement of genetic instability in the downregulation of sFRP1 in Chinese patients with hepatocellular carcinoma.

Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma in Taiwan

Loss of Heterozygosity on Chromosome 10Q22-10Q23 and 22q 11.2- 22q 12.1 and P53 Gene in Primary Hepatocellular Carcinoma

Loss of heterozygosity at chromosomal 1p36 in small hepatocellular carcinoma patients

Relation of HCC to Loss of Heterozygosity

Genetic Aberration in Primary Hepatocellular Carcinoma: Correlation Between P53 Gene Mutation and Loss-of-hetero- Zygosity on Chromosome 16Q21-Q23 and 9P21-P23

[Loss of Heterozygosity of Plasma Circulating DNA from Hepatocellular Carcinoma Patients and Its Clinical Significance].

Detection and significance of loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas

Significance of loss of heterozygosity chromosome 1 in hepatocellular carcinoma

The Association of Frequent Allelic Loss on 17p13.1 with Early Metastastic Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Allelic Loss And Gain, But Not Genomic Instability, As The Major Somatic Mutation In Primary Hepatocellular Carcinoma

Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis

Clinical Significance of Heterozygosity Loss at Mfn2 Gene in Hepatocellular Carcinoma

Loss of Heterozygosity of the Tumor Suppressor Gene Tg737 in the Side Population Cells of Hepatocellular Carcinomas is Associated with Poor Prognosis

Ioss of Heterozygosity on Chromosomes 8 and 16 in Primary Hepatocellular Carcinoma

[Microsatellite Alterations of Circulating DNA in the Plasma of Patients with Hepatocellular Carcinoma].

The Roles of Loss of Heterozygosity at 8p22 in the Molecular Classification of Patients with Hepatocellular Carcinoma, with Special Reference to Survival after Surgical Operation

Loss of Heterozygosity Analysis on Chromosome 8p in Hepatocellular Carcinoma Based on Laser Capture Microdissection

Deletion of Chromosomes 9p and 17 Associated with Abnormal Expression of P53, P16/Mts1 and P15/Mts2 Gene Protein in Hepatocellular Carcinomas